Introduction: Who Should Undergo Diagnostics and When

Genital herpes is caused by the herpes simplex virus, which comes in two types: HSV-1 and HSV-2. While HSV-2 has traditionally been the main cause of genital infections, HSV-1—commonly known for causing cold sores around the mouth—is increasingly responsible for genital herpes cases, especially among younger adults.^[1] The challenge with this infection is that many people infected with the virus experience no symptoms at all or have symptoms so mild they mistake them for something else, like a pimple or ingrown hair.^[2]

Anyone who is sexually active should consider diagnostic testing if they notice any unusual symptoms in the genital area. These symptoms might include small bumps or blisters, painful sores, itching, burning sensations, or pain during urination.^[4] However, it’s important to understand that symptoms can appear days, weeks, months, or even years after exposure to the virus, which means you might have been infected long before any signs show up.^[6]

You should seek diagnostic testing as soon as possible if you develop any sores or blisters around your genitals, anus, thighs, or buttocks. Even if you haven’t had sexual contact for a long time, testing is still advisable because the virus can remain dormant in your body and symptoms may emerge much later.^[6] It’s also wise to get tested if your sexual partner has been diagnosed with genital herpes or has symptoms of a sexually transmitted infection, even if you personally feel fine.^[1]

People who have multiple sexual partners or who engage in unprotected sex are at higher risk and may benefit from regular screening, even in the absence of symptoms. This is because the herpes virus can be transmitted even when no visible sores are present—a phenomenon known as asymptomatic shedding.^[5] During these periods, the virus can be present on the skin surface without causing any noticeable signs, yet still capable of infecting a sexual partner.

Women who are pregnant or planning to become pregnant should inform their healthcare provider if they or their partner have genital herpes. This is crucial because herpes can be passed to a baby during childbirth, potentially causing serious complications.^[7] Early diagnosis and proper management during pregnancy can significantly reduce this risk.

Additionally, anyone diagnosed with genital herpes should also be tested for HIV. Research shows that having genital herpes increases the risk of acquiring HIV by two to three times, because the open sores provide an entry point for the virus.^[10] If you already have both infections, the presence of genital herpes can also increase the likelihood of transmitting HIV to others during sexual contact.^[1]

Diagnostic Methods: How Genital Herpes Is Identified

Diagnosing genital herpes can be challenging because the classic symptoms—painful blisters and sores—aren’t always present when someone seeks medical care. Many infected individuals have mild or unrecognized symptoms, and some never develop visible sores at all.^[10] This is why laboratory testing plays such a crucial role in confirming whether someone has the herpes virus.

Physical Examination

The diagnostic process typically begins with a thorough physical examination by a healthcare provider. During this exam, the doctor or nurse will ask about your symptoms, your sexual history, and any concerns you have about potential exposure to sexually transmitted infections.^[6] They will visually inspect the affected areas—such as the genitals, anus, buttocks, or thighs—looking for any characteristic signs of herpes.

Genital herpes sores usually appear as small blisters that cluster together. These blisters eventually break open to form painful, red ulcers that may ooze or bleed before forming scabs and healing.^[2] The appearance of these lesions can sometimes allow an experienced clinician to suspect herpes based on visual inspection alone. However, because other conditions can cause similar-looking sores, visual diagnosis is not considered definitive and should always be confirmed with laboratory testing.^[9]

Virologic Testing: The Gold Standard

The most accurate way to diagnose genital herpes is through virologic testing of fluid taken directly from a blister or sore. This type of testing detects the actual virus and can determine whether the infection is caused by HSV-1 or HSV-2—information that is important for understanding your prognosis and counseling you about future outbreaks.^[10]

There are several types of virologic tests available:

• Nucleic acid amplification tests (NAAT), such as polymerase chain reaction or PCR, are currently the most sensitive tests for detecting herpes simplex virus. These tests can identify even small amounts of viral genetic material in samples taken from lesions. NAAT tests have a sensitivity ranging from about 91% to 100%, meaning they rarely miss an active infection when sores are present.^[10]
• Viral culture involves taking a swab from an active sore and trying to grow the virus in a laboratory. While this method has been used for many years, it is less sensitive than NAAT, especially if the sores are already starting to heal or if the infection is recurrent rather than a first outbreak.^[10] The sensitivity of viral culture decreases rapidly as lesions age, which is why it’s important to get tested as early as possible when sores first appear.^[12]
• Once the virus is isolated through culture or detected by NAAT, it must be typed to determine whether it’s HSV-1 or HSV-2. This distinction matters because HSV-2 causes more frequent recurrent outbreaks in the genital area compared to HSV-1.^[10]

It’s important to understand that if you don’t have any visible sores or blisters at the time of testing, these virologic tests cannot be performed on lesions. The virus is most easily detected when active sores are present. If lesions have already healed or if you’ve never had visible symptoms, blood testing becomes the alternative diagnostic approach.^[10]

Blood Tests: Type-Specific Serologic Testing

Blood tests, also called serologic tests, detect antibodies that your immune system produces in response to herpes infection. These antibodies develop within the first few weeks after infection and remain in your body for life.^[10] Blood tests can be useful when you don’t have active sores or when you want to know if you’ve ever been infected with herpes in the past.

The most accurate blood tests are type-specific serologic assays, which can distinguish between antibodies to HSV-1 and antibodies to HSV-2. These tests look for antibodies against specific viral proteins—particularly a protein called glycoprotein G, which is different for HSV-1 (gG1) and HSV-2 (gG2).^[10] This distinction is crucial because many people have HSV-1 from oral herpes (cold sores), and knowing whether you also have HSV-2 can help predict the likelihood of genital symptoms and recurrences.

However, blood tests do have some limitations. They cannot tell you where on your body you have the infection—whether it’s oral or genital—because antibodies circulate throughout your entire bloodstream.^[19] They also cannot tell you when you were infected or who you got the virus from.^[6] Additionally, it takes several weeks after initial infection for antibodies to develop to detectable levels, so a blood test performed too soon after exposure might give a false-negative result.

Testing Approaches That Are Not Recommended

Some older diagnostic methods are no longer considered reliable for genital herpes diagnosis. For example, the Tzanck preparation—a test that looks at cells scraped from a sore under a microscope—is insensitive and cannot distinguish between HSV and other viruses, so it should not be used.^[10] Similarly, direct immunofluorescence tests using antibodies to detect viral proteins have poor sensitivity and are not recommended.^[10]

It’s also worth noting that standard sexually transmitted infection screening panels may not automatically include herpes testing unless you specifically request it. If you’re concerned about herpes, make sure to discuss this with your healthcare provider so appropriate tests can be ordered.^[19]

What Happens During the Testing Process

If you visit a sexual health clinic or your doctor’s office with symptoms of genital herpes, the healthcare provider will first ask about your symptoms and sexual partners. They will then perform a visual examination of the affected area.^[6] If you have visible blisters or sores, the provider will use a small cotton swab to collect fluid from one of the lesions for laboratory testing. This process is quick and usually causes only minimal discomfort.

The sample will be sent to a laboratory where it will be analyzed using NAAT or viral culture techniques. Results are typically available within a few days, although some clinics with on-site testing capabilities may provide faster turnaround times.^[6] If you’re having a blood test, a small blood sample will be drawn from your arm, and results are usually available within a week.

If you’ve had symptoms for more than five days before seeking medical care, it may be too late to collect a sample from lesions, but you can still be tested to determine if herpes is the cause of your symptoms. Your provider may recommend blood testing instead, or simply treat your symptoms based on clinical presentation while awaiting test results.^[6]

Diagnostics for Clinical Trial Qualification

Clinical trials testing new treatments or prevention strategies for genital herpes have specific diagnostic requirements to ensure that participants truly have the condition being studied. The diagnostic criteria used for enrolling patients in research studies are typically more rigorous than what might be required for routine clinical care.

For most clinical trials involving genital herpes, participants must have laboratory-confirmed infection with either HSV-1 or HSV-2. This confirmation usually comes from type-specific virologic testing—either NAAT or viral culture—performed on samples collected from active genital lesions.^[10] Some studies may also accept type-specific serologic testing (blood tests) showing the presence of HSV-2 antibodies, particularly for trials studying suppressive therapy in people with recurrent outbreaks.

The reason for requiring laboratory confirmation is to ensure accuracy in the study population. Because many conditions can mimic genital herpes symptoms, relying on clinical diagnosis alone could lead to enrolling participants who don’t actually have herpes, which would compromise the validity of the trial results. Type-specific testing also ensures that researchers know exactly which virus type—HSV-1 or HSV-2—is present, as this can affect treatment response and recurrence patterns.

Trials studying new antiviral medications often require participants to have documented recurrent genital herpes with a minimum number of outbreaks per year—commonly at least four to six episodes annually.^[13] This requirement ensures that the study population is likely to experience outbreaks during the trial period, allowing researchers to assess whether the experimental treatment reduces outbreak frequency or severity.

For vaccine trials or studies examining transmission prevention, both partners in a couple might need to be tested. One partner must have laboratory-confirmed genital herpes (the “source partner”), while the other must test negative for the virus (the “susceptible partner”). This design allows researchers to study whether an intervention can prevent transmission from an infected person to an uninfected partner.

Clinical trials may also use diagnostic testing to monitor participants throughout the study. This could include regular blood tests to check antibody levels, periodic swabs from the genital area to detect asymptomatic viral shedding, or testing of any lesions that develop during the trial to confirm they are indeed herpes outbreaks and not caused by something else.

Before enrolling in any clinical trial for genital herpes, potential participants should expect to undergo comprehensive diagnostic testing that may include a combination of physical examination, viral testing from lesions (if present), and type-specific blood tests. These tests help researchers accurately categorize participants and ensure the safety and scientific validity of the study.